The levels of IL-2, IL-4, IL-10 and LITAF expression in APS treatment groups was greater than for the control group; suggesting that APS most probably stimulated cytokine production through B lymphocyte and macrophage activation. This evidence concerns the gene IL10 and autoimmune polyendocrinopathy.